Free Trial
LON:ABDX

Abingdon Health (ABDX) Share Price, News & Analysis

Abingdon Health logo
GBX 7.75
0.00 (0.00%)
(As of 11/1/2024 ET)

About Abingdon Health Stock (LON:ABDX)

Key Stats

Today's Range
7.75
7.75
50-Day Range
7.71
10.14
52-Week Range
6.50
13
Volume
24,884 shs
Average Volume
224,260 shs
Market Capitalization
£14.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays. It also offers AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader; and Salistick, a rapid saliva-based pregnancy test. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it offers regulatory consultancy services for businesses in the diagnostics sector. The company has a strategic collaboration with DeepVerge plc for the development, manufacturing, and commercialization of lateral flow tests; and Vatic Health Limited for the development, manufacturing, and commercialization of infectious disease lateral flow self-tests. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Receive ABDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter.

ABDX Stock News Headlines

Abingdon Health Plc's (LON:ABDX) Path To Profitability
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines

ABDX Stock Analysis - Frequently Asked Questions

Abingdon Health's stock was trading at GBX 11 at the beginning of the year. Since then, ABDX shares have decreased by 29.5% and is now trading at GBX 7.75.
View the best growth stocks for 2024 here
.

Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME).

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

Net Income
£-1,270,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£6.13 million
Cash Flow
GBX 3.44 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£14.69 million
Optionable
Not Optionable
Beta
0.13
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:ABDX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners